Also listed on Human Genome Sciences, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Collateral for a security interest recorded Sep 30, 2024 (Wells Fargo Bank, National Association).
Term ends Sep 14, 2027 · High confidence
20-year base term ended Jun 25, 2023
Filed Jun 25, 2003 as application 10/602,727 · Granted Oct 13, 2009
Base term plus 1542 days of patent term adjustment (USPTO delay)
Today
2003
2027
Clock starts
Jun 25, 2003
Jun 25, 2003
Term ends
Sep 14, 2027
Sep 14, 2027
Granted
Oct 13, 2009
Oct 13, 2009
base term
patent term adjustment
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
1,542
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
This patent's term runs 1542 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 25, 2003, when this application, 10/602,727, was filed | Jun 25, 2023 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +1542 days, USPTO patent term adjustment record | Sep 14, 2027 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Sep 14, 2027 | High confidence |
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 9, 2003 Reel 14777, frame 554 | Rosen, Craig A.; Laird, Michael W.; Gentz, Reiner L. | Human Gemone Sciences, Inc. | Assignment of Assignor's Interest |
| Nov 21, 2017 Reel 44190, frame 682 | Human Genome Sciences, Inc. | Emergent Manufacturing Operations Baltimore LLC | Assignment of Assignor's Interest |
| Jan 5, 2018 Reel 45009, frame 728 | Human Genome Sciences, Inc. | Emergent Manufacturing Operations Baltimore LLC | Corrective Assignment to Correct the Assignee's Address Previously Recorded at Reel: 044190 Frame: 0682. Assignor(S) Hereby Confirms the Assignment . |
| May 18, 2023 Reel 63690, frame 20 | Emergent Manufacturing Operations Baltimore LLC | Wells Fargo Bank, National Association, as Administrative Agent | Security Interest |
| Sep 3, 2024 Reel 68828, frame 233 | Emergent Biodefense Operations Lansing LLC; Emergent Biosolutions Canada Inc.; Emergent Biosolutions Inc.; Emergent Manufacturing Operations Baltimore LLC; Emergent Product Development Gaithersburg Inc.; Emergent Travel Health Inc. | Oha Agency LLC | Notice of Grant of Security Interest in U.S. Patents |
| Sep 3, 2024 Reel 68829, frame 337 | Wells Fargo Bank, National Association | Emergent Manufacturing Operations Baltimore LLC | Notice of Release of Security Interest in Patents |
| Sep 30, 2024 Reel 68746, frame 698 | Emergent Biodefense Operations Lansing LLC; Emergent Biosolutions Inc.; Emergent Product Development Gaithersburg Inc.; Emergent Manufacturing Operations Baltimore LLC; Emergent Travel Health Inc.; Emergent Biosolutions Canada Inc. | Wells Fargo Bank, National Association | Security Interest |
| Apr 16, 2026 Reel 74389, frame 54 | Emergent Biosolutions Inc.; Emergent Biodefense Operations Lansing LLC; Emergent Product Development Gaithersburg Inc.; Emergent Travel Health Inc.; Emergent Manufacturing Operations Baltimore LLC | Orbimed Royalty & Credit Opportunities V, LP, as Administrative Agent | Security Interest |
| Apr 29, 2026 Reel 74509, frame 627 | Oha Agency LLC, in Its Capacity as Administrative Agent | Emergent Manufacturing Operations Baltimore LLC | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Sep 2027
Term ends Sep 14, 2027. No further fees fall due before then
Note
The 1542 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
20
later US patents cite this one
That is above the median of utility patents granted in 2009 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.